Clinical Trials Browser

Interventional × Breast Neoplasms × Panitumumab × Clear all

NCT02876107 2026-04-15

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02593175 2025-11-06

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

Phase 2 Completed

43 enrolled 8 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01036087 2023-03-30

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

Phase 2 Completed

47 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01009983 2018-07-06

Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer

Phase 2 Terminated

14 enrolled 11 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00894504 2015-05-15

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

Phase 2 Completed

71 enrolled 7 charts

Breast Neoplasms

NCT00933517 2014-03-21

TVA

Phase 2 Completed

Breast Neoplasms